BioStem Technologies has opened its new laboratory and corporate offices in Pompano Beach, FL, enabling it to leverage its vertical integration strategy in the health, wellness and biotechnology sectors. The lab will serve as the quality, R&D, and pharmaceutical manufacturing laboratory, not only for the company’s in-house operations, but also for its contract formulation and contract manufacturing services.

The Company is in the process of finalizing its certifications for the ISO 8, 7, and 5 suites, as well as validation of the cGMP and cGLP areas. Corporate operations are expected to move to the new facility in the second quarter of 2017, while the operations of qualified pharma ingredients, one of the company’s subsidiaries, will remain at its current location in Oakland Park, FL.

“With the recent regulation changes we amended our original facility design to comply with FDA 503b regulations, which caused an extension to our timeline, but I couldn’t be prouder of this new state-of-the-art facility,” said Henry Van Vurst, founder and chief executive officer, BioStem.